<DOC>
	<DOCNO>NCT02678507</DOCNO>
	<brief_summary>The purpose study evaluate validity reproducibility POMAQ identify opioid abuse misuse behavior among participant chronic pain require long-term opioid use .</brief_summary>
	<brief_title>A Quantitative Study Assess Construct Validity Prescription Opioid Misuse Abuse Questionnaire</brief_title>
	<detailed_description>The Food Drug Administration ( FDA ) request , part Post-marketing requirement ( PMR ) new drug application ( NDA ) holder extend release/long-acting ( ER/LA ) opioids , conduct study develop validate measure opioid-related adverse event misuse abuse among patient chronic pain prescribe long-term opioid therapy . This measure use ass misuse abuse PMR Study 2065-1A PMR Study 2065-4B . To date , tool currently exist address need PMR except Self-Report Misuse , Abuse Diversion Prescription ( Rx ) Opioids questionnaire ( SR-MAD ) undergone several round content validation require validation . The SR-MAD substantially modify meet need PMR Studies 2065-1A 2065-4B rename Prescription Opioid Misuse Abuse Questionnaire ( POMAQ ) . The POMAQ undergo content validation via qualitative interview ( Protocol 2065-2A [ Qualitative ] ) prior use validation study ( Protocol 2065-2A [ Quantitative ] ) . This quantitative study seek develop validate POMAQ follow general tenant accord Food Drug Administration ( FDA ) Guidance Industry , Patient-Reported Outcome Measures : Use Medical Product Development Support Labeling Claims ( FDA 2009 ) emphasize importance conduct sound psychometric evaluation patient-reported instrument quantitative research method . However , note POMAQ typical PRO measure capture specific latent construct specify analytic approach POMAQ reflect difference theoretical framework .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>1 . Age ≥ 18 year ; 2 . Diagnosed chronic pain ( ≥ 3 month ) condition require longterm treatment opioids ; 3 . Willingness provide write informed consent ; 4 . Able participate complete Internetbased survey telephone interview English . 1 . Cognitive impairment base Principal Investigator 's judgment would interfere ability participant complete validation study 2 . Terminal illness life expectancy &lt; 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>